New presbyopia treatments offer promise, challenges, and rewards for practice managers

Expert advice offers key practice management tips for making presbyopia drops an integrated part of a clinical armamentarium.

Aerie doses first patient in COMET-3 study for DED treatment

COMET-3 is the second of 3 studies in the AR-15512 Registrational Phase 3 Program, which is slated for completion by 2023.

Evolution of in-office glaucoma surgical procedures

A growing number of less complex and invasive treatments are offering ODs more options for patient care.